AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Angiogenex Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Angiogenex Inc market cap is $6,100.00.
What is the 52-week high for Angiogenex Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Angiogenex Inc 52 week high is $0.1313 as of October 14, 2025.
What is the 52-week low for Angiogenex Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Angiogenex Inc 52 week low is $0.0002 as of October 14, 2025.
What is Angiogenex Inc stock price today?
Angiogenex Inc stock price today is $0.0002.
What was Angiogenex Inc stock price yesterday?
Angiogenex Inc stock price yesterday was $0.0004.
What is the 50-day moving average of Angiogenex Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Angiogenex Inc 50-day moving average is $0.0002.